Drug Database
Back to search

Poland· PL-100377629

Inhixa

A enoxaparin product containing enoxaparinum natricum, registered in Poland by Techdow Pharma Netherland B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC B01AB05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedInhixaATCB01AB05REGISTER NO.PL-100377629PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about enoxaparinum natricumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Enoxaparin is registered in 16 of 19 countries.

Countries holding a registration under ATC B01AB05 (enoxaparin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search enoxaparin products by name

Enoxaparin · ATC B01AB05

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Enoxaparinum natricum
Manufacturer
Techdow Pharma Netherland B.V.
Country
Poland (PL)
ATC code
B01AB05
ATC class
Enoxaparin
Defined daily dose
2 TSD, E
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991334628

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

203 interactions on record for enoxaparin.

Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check enoxaparin against other medicinesHow interaction checks work

Enoxaparin · interactions on record

203 records

  • 106 severe
  • 73 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe

24 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Enoxaparin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All enoxaparin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fcf9cd9f-9a04-4ce6-a9c2-16ad1525b7ca
GET /v1/drugs/fcf9cd9f-9a04-4ce6-a9c2-16ad1525b7ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "8000 j.m. (80 mg)",
  "packaging": "Rp ¦ EU/1/16/1132/007 ¦ 117908\n2 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/008 ¦ 117909\n10 amp.-strzyk. 0,8 ml\n05909991334628 ¦ Rp ¦ EU/1/16/113/017 ¦ 123036\n2 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/113/018 ¦ 123037\n10 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/059 ¦ 135831\n2 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/040 ¦ 135832\n6 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/039 ¦ 135833\n6 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/060 ¦ 135834\n10 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/029 ¦ 135835\n12 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/030 ¦ 135836\n24 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/047 ¦ 135837\n30 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/048 ¦ 135838\n30 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/084 ¦ 135839\n50 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/113 ¦ 152507\n50 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/106 ¦ 152508\n50 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/112 ¦ 152509\n20 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/088 ¦ 152510\n6 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/093 ¦ 152511\n10 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/104 ¦ 152512\n20 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/105 ¦ 152513\n24 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/123 ¦ 159477\n24 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/121 ¦ 159478\n12 amp.-strzyk. 0,8 ml\nRp ¦ EU/1/16/1132/122 ¦ 159479\n20 amp.-strzyk. 0,8 ml",
  "substance": "Enoxaparinum natricum 8000 j.m. (80 mg)",
  "common_name": "Enoxaparinum natricum",
  "pl_product_id": "100377629",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about enoxaparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console